Last reviewed · How we verify
NCT04543149
Immune Cells in Patients With Granulomatous Mastitis
trial testing Flow cytometric immunophenotyping in Granulomatous Mastitis in 35 participants. Completed in 10 October 2020.
1 October 2020
Quick facts
| Lead sponsor | Istanbul Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 35 |
| Start date | 1 August 2020 |
| Primary completion | 1 October 2020 |
| Estimated completion | 10 October 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Flow cytometric immunophenotyping
Conditions studied
- Granulomatous Mastitis — all drugs for Granulomatous Mastitis →
Sponsor
Istanbul Training and Research Hospital
Who can join
Adults 18 to 80, female only, with Granulomatous Mastitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Granulomatous mastitis is a rare, chronic, benign inflammatory disease of the breast that plays a role in many varying etiologies, including infectious and non-infectious causes. Etiological reasons were examined in various studies, but neither etiology nor definite criteria for diagnosis were found. Our aim in this study is to examine the role of immunophenotyping in differentiating the etiology of granulomatous mastitis and using it as a prognostic marker.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04543149
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Flow cytometric immunophenotyping
Trials testing the same drug.
- NCT06369662 — CD155 Expression in Acute Myeloid Leukemia · completed
Other recruiting trials for Granulomatous Mastitis
Currently open trials in the same condition.
- NCT06712524 — Effect of Different Surgical Approaches of Granulomatous Mastitis · NA · recruiting
- NCT06665399 — Observation Alone for Mild Non-Lactational Mastitis · recruiting
- NCT06667609 — Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mast · active not recruiting
- NCT06565845 — Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis · recruiting
Other Istanbul Training and Research Hospital trials
Trials by the same sponsor.
- NCT07499713 — Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata · enrolling by invitation
- NCT07335822 — The Effectiveness of Low-Level Laser Therapy in the Treatment of Meralgia Paresthetica · NA · recruiting
- NCT07363187 — Nailfold Capillaroscopy and Endothelial Biomarkers in Healthcare Workers Exposed to Chronic Low-Dose Ionizing Radiation · not yet recruiting
- NCT07415291 — CNN-Based AI Versus Physicians for Solitary Skin Lesion Diagnosis · active not recruiting
- NCT07150702 — Effects of Close Follow-up on Patients With Low Back Pain · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04543149 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Training and Research Hospital
- Last refreshed: 12 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04543149.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing